Trials / Completed
CompletedNCT05671393
the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma
A Multi-institution Real-world Study of the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 801 (actual)
- Sponsor
- Fujian Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Due to lacking of evidence on surveillance for gastric neuroendocrine carcinoma (G-NEC), this study aimed to determine the optimal postsurgical surveillance strategy for G-NEC patients and compare its cost-effectiveness with traditional surveillance strategies.
Detailed description
The development of existing follow-up strategies is mainly based on experts' consensus and researches on recurrence patterns due to the lack of direct evidence and unified standards. On the one hand, it is unreasonable to carry out the same postoperative surveillance for all G-NEC patients. In addition to the early detection of recurrence, the optimal follow-up strategy should also balance cost and effectiveness. There were no criteria for the arrangement of follow-up in different guidelines, and the optimal postoperative follow-up strategy for patients with G-NEC remains unclear. Patients with G-NEC from 21 centers in China were included. Cost-effectiveness were assessed by Markov model.
Conditions
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2016-12-01
- Completion
- 2022-12-15
- First posted
- 2023-01-04
- Last updated
- 2023-01-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05671393. Inclusion in this directory is not an endorsement.